[Complete gastric wall necrosis after endoscopic sclerotherapy for a gastric ulcer with visible arterial stump].
METHODS
A 43-year-old man with a gastric ulcer was admitted because of sudden onset of epigastric pain, cold sweats and dizziness. He had tachycardia (100/min); his blood pressure was 120/80 mm Hg: his epigastrium was tender to palpation. There were no tarry stools.


METHODS
Haemoglobin concentration was 12.7 g/dl. WBC count 17,900/microliter. Gastroscopy revealed residual haematin and an ulcer with an arterial stump at the angular fold.


METHODS
3 ml epinephrine, diluted 1:20,000, and 13 ml of 1% polidocanol were injected around the arterial stump, most of the latter solution flowing back into the gastric lumen from the rather hard ulcer base. Haematemesis four days later necessitated laparotomy followed by gastrectomy with reconstruction and a Roux-Y anastomosis because of complete necrosis of the gastric wall. Histological examination of the surgical specimen showed chronic scarred gastric ulcer and ulcerating pangastritis with haemorrhagic necrosis of the wall and associated peritonitis, caused by accidental injection of polidocanol into the artery.


CONCLUSIONS
Since the tissue-sparing injection of epinephrine, fibrin glue or salt solution is alone effective in the endoscopic treatment of bleeding gastroduodenal ulcers, polidocanol should not be injected as well.
Scharnke
W
W
Medizinische Klinik, Kreiskrankenhaus Reutlingen.
Hust
M H
MH
Braun
B
B
Schumm
W
W
D000328:Adult; D000713:Anastomosis, Roux-en-Y; D004837:Epinephrine / Q000008:administration & dosage; D005743:Gastrectomy; D005773:Gastroscopy; D006396:Hematemesis / Q000209:etiology / Q000601:surgery; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D009336:Necrosis; D010538:Peritonitis / Q000209:etiology; D000077423:Polidocanol; D011092:Polyethylene Glycols / Q000008:administration & dosage / Q000009:adverse effects*; D012597:Sclerosing Solutions / Q000008:administration & dosage / Q000009:adverse effects*; D015911:Sclerotherapy / Q000009:adverse effects* / Q000379:methods; D013270:Stomach / Q000473:pathology*; D013276:Stomach Ulcer / Q000150:complications / Q000628:therapy*
D012597:Sclerosing Solutions; D000077423:Polidocanol; D011092:Polyethylene Glycols; D004837:Epinephrine